Amazon
Amazon shares saw a slight uptick on Wednesday as the company wrapped up its two-day Prime Big Deal Days event and introduced another move in its growing health care venture.
On Wall Street, Amazon (AMZN) climbed about 1% to $224.44, pushing just above its 21-day moving average — a level that often signals short-term investor support. Despite this rise, the stock has lagged behind the S&P 500 in 2025, up only about 2.1% so far. The slower growth comes amid concerns over tariffs and intense competition in the cloud computing space, particularly around AI services. Still, Amazon has shown some positive momentum, logging modest gains in five of its last six trading sessions.
Prime Event Draws Shoppers Ahead of the Holidays
The company’s Prime Big Deal Days sale — a smaller fall counterpart to the summer Prime Day — ran from Tuesday to Wednesday, offering exclusive discounts to Prime members. Over the years, it’s become something of a warm-up to the holiday shopping rush, giving consumers an early chance to snag deals on everything from electronics to household goods.
Analysts say this holiday season may be a bit tougher for online retailers. Economic uncertainty and tariff issues have made shoppers more cautious. According to Adobe Analytics, online sales in the U.S. are expected to grow 5.3% year-over-year for November and December — a slowdown compared to 8% growth in 2024.
Pushing Deeper into Health Care
Beyond retail, Amazon continues to double down on health care. The company announced plans to install prescription pickup kiosks inside select One Medical clinics across Los Angeles. Patients will be able to have their prescriptions sent directly to Amazon Pharmacy and pick them up at the clinic, paying through the Amazon app. Most medications will be ready within minutes, saving patients an extra trip to the drugstore.
This new service is the latest step in Amazon’s ongoing push to make prescription access more convenient. The company first entered the pharmacy business in 2020 with its purchase of PillPack, later expanding to same-day delivery pharmacies in several major cities.
Since Andy Jassy became CEO in 2021, health care has become a bigger focus for the company. Amazon’s $3.9 billion acquisition of One Medical in 2022 marked a major milestone in that effort, giving the company a strong presence in primary care.
“We continue to be very pleased with the growth and resonance of Amazon Pharmacy,” Jassy said during a July earnings call, noting that the business has grown 50% year-over-year so far in 2025.
With its latest pharmacy expansion and a steady return of consumer confidence, Amazon seems intent on proving that its ambitions go far beyond e-commerce — blending health care innovation with the same convenience that made it a household name.